Watson eyes API scale-up in India via acquisition
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals appears keen to scale up its active pharmaceutical ingredients (API) capabilities in India and believes that an acquisition may be the preferable way to build on its existing base.